Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

Hims & Hers delivered record Q1 results and expanded into Europe with the Zava acquisition. Click here to see why HIMS stock is a Hold.

HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.

“We conservatively estimate the weight loss opportunity alone in ZAVA’s existing markets to expand HIMS’ Total Addressable Market by $52.1 billion,” analyst Macdonald wrote.

Hims & Hers Health, Inc. HIMS announced its agreement to acquire ZAVA, a digital health platform in Europe. The deal, which marks a significant step toward its global expansion, will likely expand ...

New York: Telehealth platform Hims & Hers said on Tuesday it will acquire London-based startup Zava for an undisclosed amount, allowing it to launch its offerings in Germany, France and Ireland ...

Many companies have failed to disrupt the complicated U.S. healthcare market. Hims & Hers (NYSE: HIMS) may finally be succeeding in cracking the code. The online telehealth platform focuses on ...

US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava in a sign of its ambition to build its European operations, including the supply of weight-loss medicines. The ...

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...